[625,000% Gain] – Are You Ready for the Next Altcoin Boom?

All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.

Joseph Lacob Biography and Net Worth

Director of Align Technology

Joseph Lacob has served as a director of Align Technology since August 1997 and has been a partner of Kleiner Perkins Caufield & Byers (KPCB), a venture capital firm, since May 1987. In 2011, Mr. Lacob acquired The Golden State Warriors of the National Basketball Association. He is currently the Managing Partner and CEO of the Warriors. Prior to joining KPCB in 1987, Mr. Lacob was an executive with Cetus Corporation (now Chiron), FHP International, a health maintenance organization (HMO), and the management consulting firm of Booz, Allen & Hamilton. Since joining KPCB in 1987, Mr. Lacob has been closely involved with KPCB's investments in more than 50 life science companies, including the startup or incubation of a dozen ventures, and with KPCB's medical technology practice, which includes more than 30 therapeutic and diagnostic medical device companies. He was previously on the board of directors of Orexigen Therapeutics, a biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of obesity. Mr. Lacob received his B.S. degree in Biological Sciences from the University of California at Irvine, his Masters degree in Public Health from the University of California at Los Angeles and his M.B.A. from Stanford University

What is Joseph Lacob's net worth?: The estimated net worth of Joseph Lacob is at least $29.82 million as of February 29th, 2024. Mr. Lacob owns 131,994 shares of Align Technology stock worth more than $29,816,125 as of November 23rd. This net worth evaluation does not reflect any other assets that Mr. Lacob may own. Learn More about Joseph Lacob's net worth.
How do I contact Joseph Lacob?: The corporate mailing address for Mr. Lacob and other Align Technology executives is 2820 ORCHARD PARKWAY, SAN JOSE CA, 95134. Align Technology can also be reached via phone at (602) 742-2000 and via email at [email protected]. Learn More on Joseph Lacob's contact information.
Has Joseph Lacob been buying or selling shares of Align Technology?: Joseph Lacob has not been actively trading shares of Align Technology within the last three months. Most recently, Joseph Lacob sold 15,000 shares of the business's stock in a transaction on Thursday, February 29th. The shares were sold at an average price of $303.22, for a transaction totalling $4,548,300.00. Following the completion of the sale, the director now directly owns 131,994 shares of the company's stock, valued at $40,023,220.68. Learn More on Joseph Lacob's trading history.
Who are Align Technology's active insiders?: Align Technology's insider roster includes Simon Beard (Director), Kevin Burns (CFO), Julie Coletti (SVP), Kevin Dallas (Director), Robert Fitzgerald (Director), Stuart Hockridge (SVP), Joseph Hogan (CEO), Joseph Lacob (Director), C. Larkin, Jr. (Director), John Morici (CFO), George Morrow (Director), Thomas Prescott (Director), Vamsi Pudipeddi (CMO), Zelko Relic (SVP), Andrea Saia (Director), Yuval Shaked (SVP), Julie Tay (SVP), Warren Thaler (Director), and Emory Wright (SVP). Learn More on Align Technology's active insiders.
Are insiders buying or selling shares of Align Technology?: During the last year, Align Technology insiders bought shares 1 times. They purchased a total of 6,500 shares worth more than $1,529,645.00. During the last year, insiders at the medical equipment provider sold shares 3 times. They sold a total of 27,524 shares worth more than $8,403,923.80. The most recent insider tranaction occured on August, 15th when Director C Raymond Larkin Jr bought 6,500 shares worth more than $1,529,645.00. Insiders at Align Technology own 0.6% of the company. Learn More about insider trades at Align Technology.
Information on this page was last updated on 8/15/2024.

Joseph Lacob Insider Trading History at Align Technology

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/29/2024	Sell	15,000	$303.22	$4,548,300.00	131,994
2/27/2024	Sell	10,000	$313.01	$3,130,100.00	146,994
8/31/2020	Sell	10,275	$299.82	$3,080,650.50
5/28/2020	Sell	10,000	$251.15	$2,511,500.00
11/12/2019	Sell	7,669	$260.00	$1,993,940.00
8/28/2019	Sell	10,000	$177.64	$1,776,400.00
8/13/2019	Sell	30,000	$181.79	$5,453,700.00	564
5/14/2019	Sell	5,000	$320.00	$1,600,000.00
2/28/2019	Sell	20,000	$258.31	$5,166,200.00
11/30/2018	Sell	10,000	$231.82	$2,318,200.00
8/27/2018	Sell	10,000	$382.00	$3,820,000.00
5/31/2018	Sell	10,000	$332.38	$3,323,800.00
5/14/2018	Sell	20,000	$289.41	$5,788,200.00
5/11/2018	Sell	10,000	$285.82	$2,858,200.00
11/30/2017	Sell	29,724	$260.91	$7,755,288.84
5/31/2017	Sell	50,000	$144.98	$7,249,000.00
5/30/2017	Sell	3,874	$143.96	$557,701.04
2/28/2017	Sell	50,000	$102.67	$5,133,500.00
8/9/2013	Sell	8,000	$43.85	$350,800.00
5/31/2013	Sell	49,998	$36.16	$1,807,927.68
8/9/2012	Sell	300,000	$34.97	$10,491,000.00

Joseph Lacob Buying and Selling Activity at Align Technology

Align Technology Company Overview

Align Technology, Inc. designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth. The segment also provides Invisalign moderate, lite and express packages, and Invisalign go and Invisalign Go Plus; retention products, Invisalign training, and adjusting tools used by dental professionals during the course of treatment; and Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions. Its Imaging Systems and CAD/CAM Services segment offers iTero intraoral scanning system, a single hardware platform for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and orthodontists software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers. This segment also provides Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; Align Oral Health Suite, a digital interface designed to enhance dental consultations; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan, as well as subscription software, disposables, rentals, leases, pay per scan, and CAD/CAM software solutions. The company was incorporated in 1997 and is headquartered in Tempe, Arizona.

Today's Range

Now: $225.89

$216.61

$230.00

50 Day Range

MA: $228.54

$205.03

$257.17

2 Week Range

Now: $225.89

$196.09

$335.40

Volume

832,907 shs

Average Volume

824,864 shs

Market Capitalization

$16.86 billion

P/E Ratio

38.55

Dividend Yield

N/A

Beta

1.65